Also
- Share via
Elan Corp., a struggling Irish drug company, has ended its collaboration with Isis Pharmaceuticals of Carlsbad to develop a drug to treat hepatitis C.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
